HIMS · XBRL financial data

Hims & Hers Health financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (HIMS's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue from contracts with customers	149	272	527	872	1,477	2,348
Cost of revenue	39	67	118	157	303	614
Gross profit	109	204	409	715	1,173	1,733
Selling, general and administrative	66	184	—	—	—	—
General and administrative	5	114	98	130	168	273
Total operating expenses	125	320	477	744	1,111	1,628
Operating income (loss)	(5)	(115)	(69)	(29)	62	106
Interest income	3	—	—	—	—	—
Interest expense	0	0	—	—	—	—
Other income (expense)	0	0	3	9	10	23
Income tax expense (benefit)	0	(3)	(0)	2	(54)	(4)
Net income (loss)	(3)	(108)	(66)	(24)	126	128
Earnings per share, basic USD per share	(0.51)	(0.58)	(0.32)	(0.11)	0.58	0.57
Earnings per share, diluted USD per share	(0.51)	(0.58)	(0.32)	(0.11)	0.53	0.51
Weighted average shares, basic millions of shares	35	187	205	209	216	225
Weighted average shares, diluted millions of shares	35	187	205	209	237	258

Fiscal years (HIMS's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	1	72	47	97	221	229
Marketable securities	73	175	133	124	80	349
Marketable securities, non-current	—	—	—	—	0	351
Accounts receivable	1	4	4	7	6	32
Inventory	4	14	22	22	64	80
Prepaid and other current assets	5	9	15	22	31	110
Total current assets	1	270	217	265	396	768
Property and equipment, net	2	2	3	—	—	—
Right-of-use asset	0	5	5	10	11	137
Goodwill	0	111	111	111	113	278
Total assets	206	421	366	441	708	2,155
Accounts payable	0	20	32	43	91	143
Accrued liabilities	4	12	12	29	53	79
Total current liabilities	5	79	48	88	221	404
Lease liability, non-current	0	4	4	9	9	143
Total liabilities	12	86	55	97	231	1,614
Accumulated deficit	(2)	(279)	(345)	(368)	(242)	(114)
Total stockholders' equity	5	335	312	344	477	541
Total liabilities and equity	206	421	366	441	708	2,155

Fiscal years (HIMS's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	(3)	(108)	(66)	(24)	126	128
Stock-based compensation	6	67	43	66	92	135
Depreciation and amortization	1	4	7	10	17	55
Net cash from operating activities	(1)	(34)	(27)	73	251	300
Net cash from investing activities	0	(156)	35	(12)	(19)	(1,025)
Share repurchases	0	22	0	2	83	90
Proceeds from long-term debt	0	0	—	—	—	—
Repayments of long-term debt	2	0	0	—	—	—
Net cash from financing activities	48	235	(33)	(11)	(108)	730
Net change in cash	6	44	(25)	50	124	7

SIC 8011 and related industry codes, similar size; rows marked “added: same SIC” fill a short list. Each row is the latest quarter reported.

How peers are chosen

SIC 8011 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Fewer than three companies fall in that range, so the list adds same-SIC (8011) companies nearest in public float, each marked “added: same SIC”.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.
A cell reading “year only” links to a 10-K that gives only the full year: without all three earlier quarters there is no fourth quarter to work out, and the year total is never shown as a quarter.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Runway	Quarter
Hims & Hers Health	610	753	(36)*	not reported	—	Q2 FY26 10-QJun 30, 2026
Teladoc Healthadded: same SIC	850	605	106*	182.3M	—	Q3 FY26 10-QSep 30, 2026
LifeMDadded: same SIC	25	47	(6.9)*	48.2M	3.6 quarters	Q2 FY26 10-QJun 30, 2026
Starling Oncologyadded: same SIC	41	161	12*	101.9M	—	Q2 FY26 10-QJun 30, 2026
Airsculpt Technologiesadded: same SIC	19	43	(1.2)*	72.1M	15.2 quarters	Q2 FY26 10-QJun 30, 2026
SBC Medical Group Holdingsadded: same SIC	184	49	23*	102.8M	—	Q2 FY26 10-QJun 30, 2026
Cardiff Lexingtonadded: same SIC	0.2	2.2	(0.7)*	15.6M	0.3 quarters	Q2 FY26 10-QJun 30, 2026
HealthLynkedadded: same SIC	0	not reported	(0.4)*	3.0M	0.0 quarters	Q2 FY26 10-QJun 30, 2026
Aunaadded: same SIC	236	year only	year only	not reported	—	Q4 FY24 20-F/ADec 31, 2024

Not investment advice. Not affiliated with the U.S. SEC.